Basic information about inhibitors

IPAD-DB ID	C00147
Name	Schizotenuin A
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	C 3 6 H 2 8 O 1 6
Molecular Weight	716.6g/mol
IUPAC Name	(2R)-2-[(E)-3-[3-[(1R)-1-carboxy-2-(3, 4-dihydroxyphenyl)ethoxy]carbonyl-2-(3, 4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-5-yl]prop-2-enoyl]oxy-3-(3, 4-dihydroxyphenyl)propanoic acid
InChI	InChI=1S/C36H28O16/c37-21-5-1-17(10-24(21)40)13-28(34(45)46)50-30(44)8-3-16-9-20-31(32(52-33(20)27(43)12-16)19-4-7-23(39)26(42)15-19)36(49)51-29(35(47)48)14-18-2-6-22(38)25(41)11-18/h1-12, 15, 28-29, 37-43H, 13-14H2, (H, 45, 46)(H, 47, 48)/b8-3+/t28-, 29-/m1/s1
InChIKey	KROVXXIIXUFKOO-NGJWAYPNSA-N
Canonical SMILES	C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC3=C(C(=C2)O)OC(=C3C(=O)OC(CC4=CC(=C(C=C4)O)O)C(=O)O)C5=CC(=C(C=C5)O)O)O)O
PubChem CID	46224244
DrugBank Accession Number	-
CAS Registry Number	-

Biological activity data

Ki	-
EC50	-
IC50	2.93μM(Aβ42), 0.58 µM(hIAPP)
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	Exhibited high antioxidant activity at a concentration of 50 μM
Metal Chelating	-
BBB(blood-brain barrier)	-
Target Protein	HIAPP
Effects	-
Research Models	-
Main Source	From Lycopus lucidus phenylpropanoids
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	716.6
Hac(Computed by SwissADME)	52
Volume(Computed by ADMETlab 2.0)	681.617
Density(Computed by ADMETlab 2.0)	1.051
nRing(Computed by ADMETlab 2.0)	5
MaxRing(Computed by ADMETlab 2.0)	9
nHet(Computed by ADMETlab 2.0)	16
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	33
Flexibility(Computed by ADMETlab 2.0)	0.424
Stero Centers(Computed by ADMETlab 2.0)	2
LogS(Computed by ADMETlab 2.0)	-4.065
LogD(Computed by ADMETlab 2.0)	2.017

ADMET properties

logP(Computed by ADMETlab 2.0)	4.14
TPSA(Computed by SwissADME)	281.95 Ų
Hbond Acceptor(Computed by SwissADME)	16
Hbond Donor(Computed by SwissADME)	9
Rotatable Bonds(Computed by SwissADME)	14

Pharmacokinetics

GI Absorption(Computed by SwissADME)	Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	No
P-gp Substrate(Computed by SwissADME)	No
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	No
CYP2C9 Inhibitor(Computed by SwissADME)	No
CYP2D6 Inhibitor(Computed by SwissADME)	No
CYP3A4 Inhibitor(Computed by SwissADME)	No
log Kp(Skin Permeation)(Computed by SwissADME)	-7.26 cm/s

Druglikeness

Lipinski(Computed by SwissADME)	No, 3 violations: MW>500, NorO>10, NHorOH>5
Ghose(Computed by SwissADME)	No, 3 violations: MW>480, MR>130, #atoms>70
Veber(Computed by SwissADME)	No, 2 violations: Rotors>10, TPSA>140
Egan(Computed by SwissADME)	No, 1 violation: TPSA>131.6
Muegge(Computed by SwissADME)	No, 4 violations: MW>600, TPSA>150, H-acc>10, H-don>5
Bioavailability Score(Computed by SwissADME)	0.11